Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma

Head and Neck

Volumn 20, Issue 1, 1998, Pages 1-7

  Singh, Bhuvanesh ^a   Bhaya, Mahesh ^a   Zimbler, Marc ^b   Stern, Jordan ^c   Roland, J Thomas ^b   Rosenfeld, Richard M ^a   Har El, Gady ^a   Lucente, Frank E ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c NEW YORK EYE AND EAR INFIRMARY   (United States)

Author keywords

Comorbidity; Head and neck neoplasms; Kaplan Feinstein index; Outcomes research; Squamous cell carcinoma

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER SURVIVAL; COMORBIDITY; DISEASE SEVERITY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

EID: 0000040981     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(199801)20:1<1::AID-HED1>3.0.CO;2-8     Document Type: Article

References (14)

1. Piccirillo JF, Feinstein AE. Problems in the current TNM staging system for cancer. Cancer 1996;77:834-842.
2. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-383.
3. McGuirt WF, Davis III SP. Demographic portrayal and outcomes analysis of head and neck cancer surgery in the elderly. Arch Otolaryngol Head Neck Surg 1995;121: 150-154.
4. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974;27:387-404.
5. Boyd NF, Clemens JD, Feinstein AR. Pretherapeutic morbidity in the prognostic staging of acute leukemia. Arch Intern Med 1979;139:324-328.
6. Wells CK, Stroller JK, Feinstein AR, Horowitz RI. Comorbidity and clinical determinants of prognosis in endometrial cancer. Arch Intern Med 1984;144:2004-2008.
7. Feinstein AR, Wells CK. A clinical-severity staging system for patients with lung cancer. Medicine 1990;69:1-33.
8. Piccirillo JF, Wells CK, Sasaki CT, Feinstein AR. New clinical severity staging system for cancer of the larynx. Five year-survival rates. Ann Otol Rhinol Laryngol 1994; 103:83-92.
9. Feinstein AR, Schimpff CR, Andrews JF, Wells C. Cancer of the larynx: a new staging system and a re-appraisal of prognosis and treatment. J Chron Dis 1988;30:277-305.
10. Singh B, Alfonso A, Sundaram K, Sabin S, Har-El G, Lucente FE. Outcome differences in laryngeal carcinoma in younger and older patients: a retrospective case-control study. Presentation at the Society of Head and Neck Surgeons - Annual Meeting, Cancun, Mexico, April, 1997.
11. American Joint Committee on Cancer. Manual for staging of cancer, 4th ed. Philadelphia: J.B. Lippincott, 1992.
12. Bailey BJ. Beyond the "new" TNM classification. Arch Otolaryngol Head Neck Surg 1991;117:369-370.
13. Piccirillo JF. Purposes, problems, and proposals for progress in cancer staging. Arch Otolaryngol Head Neck Surg. 1995;121:145-149.
14. Piccirillo JF. Inclusion of comorbidity in a staging system for head and neck cancer. Oncology. 1995;9:831-836.